SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Impairment losses on long-lived assets	$ 0	$ 0	$ 0	$ 0
Impairment losses on intangible assets	0	0	0	0
Impairment losses on goodwill	0	0	0	0
Reimbursement of actual costs			40,000
Revenue				$ 1,740,855
In-Vivo [Member]
Revenue			500,000
Oncotelic, Inc. [Member]
Due to related parties	$ 500,000		500,000
ATB Agreement [Member] | Japan, China, Brazil, Mexico, Russia and Korea [Member]
Marketing approval received value			1,000,000
ATB Agreement [Member] | Germany, France, Spain, Italy and UK [Member]
Marketing approval received value			2,000,000
Golden Mountain Partners LLC [Member] | Research Service Agreement [Member]
Placement agent fees			1,200,000
Autotelic BIO [Member]
Revenue		$ 500,000
Autotelic BIO [Member] | ATB Agreement [Member]
Revenue			$ 500,000